Mineralys Therapeutics, Inc. (MLYS) Insider Trading
Over the last 3 months, MLYS insiders made 0 open-market buys and 16 sales, a net sale of -$6.7M (SEC Form 4). Over the last 6 months, 187 institutions increased and 126 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
16
Net (3m)
-$6.7M
Insider trades by month Buys Sells
Mar
Apr
May
Jun
Jul
Aug
Context3-month price -18.6%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 25, 2026 | Warren Ericofficer: Chief Commercial Officer | Sell | 7,437 | $25.98 |
| Aug 25, 2026 | Warren Ericofficer: Chief Commercial Officer | Option | 7,437 | $13.24 |
| Aug 12, 2026 | Rodman David Malcomofficer: Chief Medical Officer | Option | 2,170 | $16.00 |
| Aug 12, 2026 | Rodman David Malcomofficer: Chief Medical Officer | Sell | 2,170 | $27.09 |
| Aug 12, 2026 | Ferguson James J. IIIofficer: Chief Medical Officer | Grant | 102,400 | — |
| Aug 12, 2026 | Ferguson James J. IIIofficer: Chief Medical Officer | Grant | 135,000 | $27.38 |
| Jul 23, 2026 | Warren Ericofficer: Chief Commercial Officer | Option | 7,438 | $13.24 |
| Jul 23, 2026 | Warren Ericofficer: Chief Commercial Officer | Sell | 7,438 | $26.87 |
| Jul 20, 2026 | Rodman David Malcomofficer: Chief Medical Officer | Option | 416 | $15.44 |
| Jul 20, 2026 | Rodman David Malcomofficer: Chief Medical Officer | Sell | 416 | $26.53 |
| Jul 15, 2026 | Congleton Jondirector, officer: Chief Executive Officer | Sell | 10,700 | $27.24 |
| Jul 15, 2026 | Rodman David Malcomofficer: Chief Medical Officer | Sell | 14,058 | $27.58 |
| Jul 15, 2026 | Rodman David Malcomofficer: Chief Medical Officer | Sell | 6,349 | $26.61 |
| Jul 15, 2026 | Rodman David Malcomofficer: Chief Medical Officer | Option | 3,542 | $10.20 |
| Jul 15, 2026 | Rodman David Malcomofficer: Chief Medical Officer | Option | 4,167 | $14.25 |
| Jul 15, 2026 | Rodman David Malcomofficer: Chief Medical Officer | Option | 6,349 | $1.08 |
| Jul 10, 2026 | Rodman David Malcomofficer: Chief Medical Officer | Sell | 2,171 | $30.30 |
| Jul 10, 2026 | Rodman David Malcomofficer: Chief Medical Officer | Option | 2,171 | $16.00 |
| Jun 30, 2026 | Warren Ericofficer: Chief Commercial Officer | Sell | 104,124 | $25.90 |
| Jun 30, 2026 | Warren Ericofficer: Chief Commercial Officer | Option | 104,124 | $13.24 |
| Jun 30, 2026 | Congleton Jondirector, officer: Chief Executive Officer | Sell | 17,000 | $26.82 |
| Jun 30, 2026 | Congleton Jondirector, officer: Chief Executive Officer | Sell | 58,000 | $25.94 |
| Jun 17, 2026 | Karydas Daphnedirector | Sell | 3,000 | $25.00 |
| Jun 17, 2026 | Karydas Daphnedirector | Option | 3,000 | $12.02 |
| Jun 17, 2026 | Rodman David Malcomofficer: Chief Medical Officer | Sell | 4,584 | $25.00 |
| Jun 17, 2026 | Rodman David Malcomofficer: Chief Medical Officer | Option | 3,542 | $10.20 |
| Jun 17, 2026 | Rodman David Malcomofficer: Chief Medical Officer | Option | 417 | $15.44 |
| Jun 17, 2026 | Rodman David Malcomofficer: Chief Medical Officer | Option | 4,167 | $14.25 |
| Jun 17, 2026 | Rodman David Malcomofficer: Chief Medical Officer | Sell | 9,890 | $23.81 |
| Jun 12, 2026 | Rodman David Malcomofficer: Chief Medical Officer | Sell | 6,349 | $23.93 |
Source: MLYS SEC Form 4 filings, latest Aug 25, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their MLYS positions over the last 6 months (SEC Form 13F).
Increased
187
New positions
69
Reduced
126
Sold out
23
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| Catalys Pacific, LLC | Unchanged | 7.9M | Aug 5, 2026 |
| CATALYS PACIFIC, LLC | Unchanged | 7.9M | May 14, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Increased | 7.7M | May 15, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Unchanged | 7.7M | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 5.9M | Aug 7, 2026 |
| Samsara BioCapital, LLC | Unchanged | 5.9M | Aug 14, 2026 |
| SAMSARA BIOCAPITAL, LLC | Unchanged | 5.9M | May 15, 2026 |
| FMR LLC | Reduced | 4.9M | May 15, 2026 |
| FMR LLC | Reduced | 4.5M | Aug 13, 2026 |
| BLACKROCK, INC. | Increased | 4.5M | May 13, 2026 |
| STATE STREET CORP | Increased | 4.1M | Aug 7, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | New Position | 4.0M | Aug 14, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 3.4M | May 15, 2026 |
| CAPTION MANAGEMENT, LLC | Increased | 3.3M | May 15, 2026 |
| STATE STREET CORP | Reduced | 2.9M | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.